| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/08/2009 | US7585868 Antagonists of a lipid kinase such as a PI3 kinase, protein tyrosine kinase, and/or protein serine-threonine kinases such as mTOR; 1-isopropyl-3-(3-methoxy-4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
| 09/08/2009 | US7585867 Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one |
| 09/08/2009 | US7585862 Reverse-turn mimetics and method relating thereto |
| 09/08/2009 | US7585361 Porphyrazine coloring matter, ink, ink set and colored product |
| 09/08/2009 | CA2522813C 2-alkynyl-and 2-alkenyl-pyrazolo-¬4,3-e|-1,2,4-triazolo-¬1,5-c|-pyrimidine adenosine a2a receptor antagonists |
| 09/08/2009 | CA2520901C Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents |
| 09/08/2009 | CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 09/08/2009 | CA2417758C Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches |
| 09/08/2009 | CA2316388C Tetrahydrobenzindole derivative |
| 09/03/2009 | WO2009108551A2 Heteroaryl amide analogues |
| 09/03/2009 | WO2009107767A1 Novel bicyclic pyrimidine derivative having antagonistic activity on h4 receptor |
| 09/03/2009 | WO2009106982A1 Indazole derivatives |
| 09/03/2009 | WO2009106577A1 Imidazo [1,2-b] pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease |
| 09/03/2009 | WO2009106539A1 Heterocyclic compounds as inhibitors of cxcr2 |
| 09/03/2009 | WO2009106531A1 Pyrrolopyrimidinecarboxamides |
| 09/03/2009 | WO2009106445A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106444A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106443A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106442A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106441A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009085990A3 Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221614 Selective serine/threonine kinase inhibitors |
| 09/03/2009 | US20090221612 Certain substituted amides, method of making, and method of use thereof |
| 09/03/2009 | US20090221592 New salt of sitagliptin; exhibits physicochemical properties, such as stability to stress, rendering it particularly suitable for the manufacture of various pharmaceutical dosage forms; Type 2 diabetes |
| 09/03/2009 | US20090221590 Salt of cd 80 antagonist |
| 09/03/2009 | US20090221548 Melanin concentrating hormone receptor-1 antagonists |
| 09/03/2009 | US20090221535 2-(2,5-Dioxo-5,6-dihydro-4H-imidazo[1,5,4-de]quinoxalin-1(2H)-yl)-N-(3-methyl-spiro[imidazolidine-4,2'-indane]-2,5-dione)acetamide, used as Calcitonin Gene-Related Peptide (CGRP), ligands useful in the treatment or prevention of headaches |
| 09/03/2009 | US20090221529 Heterocycles and derivatives thereof and methods of manufacture and therapeutic use |
| 09/03/2009 | US20090221519 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 09/03/2009 | CA2717034A1 Imidazo[1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease |
| 09/03/2009 | CA2716223A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/03/2009 | CA2714500A1 Heterocyclic compounds as inhibitors of cxcr2 |
| 09/03/2009 | CA2713718A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2713710A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2713324A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2712507A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2711733A1 Pyrrolopyrimidinecarboxamides |
| 09/02/2009 | EP2096110A1 Acridane-9-dithiocarboxylate derivatives for generating chemiluminescence with a peroxidase |
| 09/02/2009 | EP2094711A1 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 09/02/2009 | EP2094710A1 3,4 diaminopyridine derivatives |
| 09/02/2009 | EP2094709A1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists |
| 09/02/2009 | EP2094708A2 A pyrrolopyrazin as syk-kinase inhibitor |
| 09/02/2009 | EP2094707A1 Heterobicyclic matrix metalloprotease inhibitors |
| 09/02/2009 | EP2094706A2 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 09/02/2009 | EP2094703A1 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 09/02/2009 | EP2094689A2 Indolylmaleimide derivatives as kinase inhibitors |
| 09/02/2009 | EP2094686A1 5-{2-[4-(2-methyl-5-quinolinyl)-l-piperidinyl]ethyl} quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairement, psychotic disorders, anxiety, depression, etc. |
| 09/02/2009 | EP2094681A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
| 09/02/2009 | EP2094671A1 Heterobicyclic metalloprotease inhibitors |
| 09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 09/02/2009 | EP2094645A1 2-hydroxy-1,3-diaminopropane derivatives |
| 09/02/2009 | EP2094276A2 Anti-viral compounds |
| 09/02/2009 | EP2094081A1 Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/02/2009 | EP1651648A4 Compounds and compositions as protein kinase inhibitors |
| 09/02/2009 | EP1581535B3 Pyrrolopyridazine derivatives |
| 09/02/2009 | EP1472259B1 Tetrapyrrolic macrocycles as photodynamic agents |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | CN101522683A Pyraz0l0(l,5-A) (1, 3, 5) triazine and pyrazolo (1, 5-A) pyrimidine derivatives useful as protein kinase inhibitors |
| 09/02/2009 | CN101522682A Heterocyclic compounds as antiinflammatory agents |
| 09/02/2009 | CN101522681A Certain chemical entities, compositions and methods |
| 09/02/2009 | CN101519406A Novel synthetic method of alkyl formamine villaumite |
| 09/02/2009 | CN101519405A 8a-(trifluoro-methyl)hexahydro pyrrolo[1,2-a]pyrimidine-6(7H)-ketone and method for synthesizing same |
| 09/01/2009 | US7582774 reacting hydroxyamine with succinic anhydride, or succinic acid to produce N-hydroxysuccinimide; using solvent undergoing azeotropy with water while carrying out dewatering; oxidizing agents for use photography developers, reagents for synthetically preparing peptides; intermediates for insecticides |
| 09/01/2009 | US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 09/01/2009 | US7582762 Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline |
| 09/01/2009 | US7582752 Process for the resolution of nefopam |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582659 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci; 1-[5(R)-3-[4-[2-[(1 alpha ,5 alpha ,6 beta )-6-Cyano-3-azabicyclo[3.1.0]hexan-6-yl]pyridin-5-yl]-3-fluorophenyl]-2-oxooxazolidin-5-ylmethyl]-1,2,3-triazole; side effect reduction |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |
| 09/01/2009 | US7582631 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia |
| 09/01/2009 | US7582630 N-[3-(trifluoromethyl)phenyl]-4-{2-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-b]pyridazin-3-yl}pyrimidin-2-amine; enzyme inhibitors; inhibition/antagonism of protein kinases, glycogen synthase kinase-3-beta; central nervous system disorders; Alzheimer's disease; bipolar disorder; stroke; anticarcinogenic |
| 09/01/2009 | US7582628 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | US7582583 Shaped body containing a microporous material and at least one silicon-containing binder, method for the production thereof and its use as a catalyst, particularly in a method for producing triethylenediamine (TEDA). |
| 09/01/2009 | US7582280 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications |
| 09/01/2009 | US7582230 Contains tetrahydroxy- or tetraalkoxy-substituted phthalocyanine |
| 09/01/2009 | CA2490115C Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 09/01/2009 | CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence |
| 08/27/2009 | WO2009105210A2 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging |
| 08/27/2009 | WO2009103176A1 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 08/27/2009 | WO2009074677A3 Pyrazolotriazines |
| 08/27/2009 | WO2008027220A3 Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3, 3a-dihydropyrazol0 [1, 5-a] pyrimidin-7-yl) -amino derivatives |
| 08/27/2009 | WO2007079003A3 Amide inhibitors of leukotriene a4 hydrolase |
| 08/27/2009 | US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 08/27/2009 | US20090216023 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 08/27/2009 | US20090216015 Base Stable Ionic Liquids |
| 08/27/2009 | US20090216010 Crystalline carbapenem compound and produced method thereof |
| 08/27/2009 | US20090216004 Protoporphyrinogen oxidase having activity of imparting resistance against acifluorfen and gene thereof |
| 08/27/2009 | US20090215851 Method of Preparing a Porphyrin Derivative, a Porphyrin Derivative, Use of Said Porphyrin derivative and a pharmaceutical composition containing said porphyrin derivative |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215788 Pyrrolopyrazine kinase inhibitors |
| 08/27/2009 | US20090215785 Pyrrolopyrazine kinase inhibitors |
| 08/27/2009 | US20090215783 Composition for induction or inhibition of stem cell differentiation |
| 08/27/2009 | US20090215782 Use of PDE-5 Inhibitors for Endothelial Repair of Tissues Impaired by Trauma or Disease |
| 08/27/2009 | US20090215781 Alpha-helix mimetics and methods relating to the treatment of fibrosis |
| 08/27/2009 | US20090215778 Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives |